Cochrane Abstracts
Corticosteroids for preventing graft‐versus‐host disease after allogeneic myeloablative stem cell transplantation
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Corticosteroids for Preventing Graft‐versus‐host Disease After Allogeneic Myeloablative Stem Cell Transplantation." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433644/all/Corticosteroids_for_preventing_graft‐versus‐host_disease_after_allogeneic_myeloablative_stem_cell_transplantation.
Corticosteroids for preventing graft‐versus‐host disease after allogeneic myeloablative stem cell transplantation. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433644/all/Corticosteroids_for_preventing_graft‐versus‐host_disease_after_allogeneic_myeloablative_stem_cell_transplantation. Accessed January 17, 2025.
Corticosteroids for preventing graft‐versus‐host disease after allogeneic myeloablative stem cell transplantation. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433644/all/Corticosteroids_for_preventing_graft‐versus‐host_disease_after_allogeneic_myeloablative_stem_cell_transplantation
Corticosteroids for Preventing Graft‐versus‐host Disease After Allogeneic Myeloablative Stem Cell Transplantation [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 17]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433644/all/Corticosteroids_for_preventing_graft‐versus‐host_disease_after_allogeneic_myeloablative_stem_cell_transplantation.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Corticosteroids for preventing graft‐versus‐host disease after allogeneic myeloablative stem cell transplantation
ID - 433644
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433644/all/Corticosteroids_for_preventing_graft‐versus‐host_disease_after_allogeneic_myeloablative_stem_cell_transplantation
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
